Alprazolam upschedule cuts overall use, adverse events

Since alprazolam was rescheduled to S8, there has been a notable reduction in overall use and adverse events, a study published today has found.Interrupted Time Series Analysis of the Effect of Rescheduling Alprazolam in Australia: Taking Control of Prescription Drug Use, published in JAMA Internal Medicine, showed that the February 2014 rescheduling decision has led